barr 882 (Hydroxyurea 500 mg)
Pill imprint barr 882 has been identified as Hydroxyurea 500 mg.
Hydroxyurea is used in the treatment of thrombocythemia; anemia, sickle cell; polycythemia vera; chronic myelogenous leukemia; solid tumors (and more), and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Hydroxyurea 500 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 500 mg
- Pink & Purple
- 22.00 mm
- Prescription only
D&C Red No. 28
D&C Yellow No. 10
sodium phosphate dibasic
edetate calcium disodium
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
ferric oxide red
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|54868-4773||Physicians Total Care Inc (repackager)|
|54569-5715||A-S Medication Solutions, LLC (repackager)|
Note: Inactive ingredients may vary.
More about hydroxyurea
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.